Clarapath varieties strategic collaboration with Mayo Clinic to advance pathology tissue processing. Robotics, AI and automation assist enhance affected person outcomes and remedy laboratory labor shortages
Robotics, AI and automation assist enhance affected person outcomes and remedy laboratory labor shortages
WHITE PLAINS, N.Y., April 23, 2024, Clarapath, a medical robotics firm reworking the best way pathology laboratories course of tissue, introduced it has entered right into a strategic collaboration with Mayo Clinic to propel a brand new period of laboratory automation.
For many years, laboratories have relied on labor intensive, handbook procedures to course of tissue specimens for functions of diagnosing most cancers and different illnesses. Confronted with labor shortages, high quality management challenges, and the quickly rising quantity of samples, laboratories must innovate and enhance the reliability and effectivity of making glass slides for pathological overview. Clarapath’s SectionStar™ is an automatic tissue sectioning, switch and high quality management system that mixes robotics, computational AI, and built-in histopathology workflows, leading to standardized slide outputs and quantitative high quality metrics. This could considerably speed up pattern processing and cut back human involvement and errors.
The strategic collaboration combines Clarapath’s revolutionary tissue answer and area consultants with the scientific insights and experience of Mayo Clinic. It will allow laboratories throughout the globe to digitally remodel the standard, security, value, and throughput of their histology course of. The automation helps extra knowledgeable and quicker selections that assist enhance the supply and high quality of affected person care and permit present laboratory personnel to efficiently deal with rising case volumes. Moreover, the businesses will collaborate to develop new options to additional enhance the histopathology laboratory.
“We’re thrilled to collaborate with Mayo Clinic to advance the modernization of anatomic pathology,” stated Eric Feinstein, CEO of Clarapath. “Laboratories, like manufacturing vegetation, want fixed innovation and modernization. With SectionStar, leaders can now reimagine the histology course of to maintain up with rising caseloads and shrinking workforces. It will assist sufferers get faster check outcomes and extra speedy entry to care.”
As a part of the collaboration, Joaquín García, M.D., chair of the division of Anatomic Pathology inside the Division of Laboratory Drugs and Pathology and chair of Mayo Clinic’s Digital Pathology Program, is becoming a member of the Clarapath Board of Administrators. Mayo Clinic joins different main organizations as Clarapath stakeholders.
“Mayo Clinic is at the vanguard of technological development in anatomic pathology. Incorporating digital pathology and synthetic intelligence into our present follow has highlighted the necessity for standardizing pre-analytic processes,” stated Dr. García. “By working with Clarapath, we’re constructing the muse for a ‘lab of the long run’ that includes end-to-end automation, robotics, and AI to the affected person tissue lifecycle.”
Mayo Clinic has a monetary curiosity within the expertise referenced on this press launch. Mayo Clinic will use any income it receives to help its not-for-profit mission in affected person care, training and analysis.
About Clarapath Clarapath is a medical robotics firm aimed toward catalyzing change in the best way pathology laboratories work. Clarapath’s SectionStar is the primary (pending US launch) all-in-one tissue sectioning and switch system that dramatically will increase capability, reliability, and consistency whereas minimizing the necessity for extremely expert labor. The corporate is headquartered and runs its medical machine growth in Hawthorne, NY. It has a CLIA-certified laboratory that serves scientific and non-clinical organizations. For extra info, go to https://www.clarapath.com.